Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
CTRE Quote, Financials, Valuation and Earnings
Last price:
$30.31
Seasonality move
:
-2.81%
Day range:
$30.38 - $31.11
52-week range:
$24.79 - $33.15
Dividend yield:
4.11%
P/E ratio:
33.05x
P/S ratio:
20.82x
P/B ratio:
1.99x
Volume:
1.7M
Avg. volume:
1.9M
1-year change:
12.5%
Market cap:
$5.8B
Revenue:
$228.3M
EPS (TTM):
$0.92
Analysts' Opinion
-
Consensus RatingCareTrust REIT has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $33.22, CareTrust REIT has an estimated upside of 9.25% from its current price of $30.41.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $32.00 representing 100% downside risk from its current price of $30.41.
Fair Value
-
According to the consensus of 8 analysts, CareTrust REIT has 9.25% upside to fair value with a price target of $33.22 per share.
CTRE vs. S&P 500
-
Over the past 5 trading days, CareTrust REIT has underperformed the S&P 500 by -1.87% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CareTrust REIT does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CareTrust REIT has grown year-over-year revenues for 9 quarters straight. In the most recent quarter CareTrust REIT reported revenues of $71.6M.
Earnings Growth
-
CareTrust REIT has grown year-over-year earnings for 3 quarters straight. In the most recent quarter CareTrust REIT reported earnings per share of $0.35.
Enterprise value:
6.6B
EV / Invested capital:
--
Price / LTM sales:
20.82x
EV / EBIT:
35.05x
EV / Revenue:
26.97x
PEG ratio (5yr expected):
0.41x
EV / Free cash flow:
25.87x
Price / Operating cash flow:
19.97x
Enterprise value / EBITDA:
26.50x
Gross Profit (TTM):
$233.1M
Return On Assets:
5.3%
Net Income Margin (TTM):
65.8%
Return On Equity:
6.8%
Return On Invested Capital:
5.48%
Operating Margin:
59.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $187.7M | $205.9M | $246.4M | $53.5M | $71.6M | |
| Gross Profit | $178.3M | $195.7M | $233.1M | $51M | $69.5M | |
| Operating Income | $109.3M | $119.7M | $135.9M | $30.8M | $42.6M | |
| EBITDA | $138.1M | $155M | $250.8M | $50.4M | $89.7M | |
| Diluted EPS | $0.56 | $0.51 | $0.92 | $0.22 | $0.35 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $39.7M | $175.1M | $75.5M | $464.1M | $747.8M | |
| Total Assets | $1.6B | $1.6B | $1.6B | $2.3B | $3.9B | |
| Current Liabilities | $212.8M | $155.7M | $187.1M | $76.5M | $114.1M | |
| Total Liabilities | $708.7M | $749.4M | $781.9M | $672.3M | $936.3M | |
| Total Equity | $925.4M | $844.6M | $840.3M | $1.7B | $2.9B | |
| Total Debt | $665.8M | $698.7M | $729.8M | $595.9M | $822.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $145M | $168.5M | $266.8M | $48.8M | $71.4M | |
| Cash From Investing | -$104.1M | -$390.2M | -$1.4B | -$123.2M | -$35.9M | |
| Cash From Financing | -$39.3M | $644.9M | $1.3B | $231.1M | $383.2M | |
| Free Cash Flow | $137.6M | $159.1M | $256.9M | $48.4M | $69.1M | |
CTRE
Sector
Market Cap
$5.8B
$1B
Price % of 52-Week High
91.74%
84.86%
Dividend Yield
4.11%
3.17%
Shareholder Yield
-20.84%
4.03%
1-Year Price Total Return
12.51%
--
Beta (5-Year)
0.844
0.765
Dividend yield:
4.11%
Annualized payout:
$1.16
Payout ratio:
117.2%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$30.84
200-day SMA
Buy
Level
$28.77
Bollinger Bands (100)
Buy
Level
27.22 - 30.06
Chaikin Money Flow
Buy
Level
6.5M
20-day SMA
Sell
Level
$30.59
Relative Strength Index (RSI14)
Buy
Level
52.16
ADX Line
Buy
Level
15.54
Williams %R
Neutral
Level
-68.3386
50-day SMA
Buy
Level
$29.55
MACD (12, 26)
Buy
Level
0.45
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
7.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.0665)
Buy
CA Score
(Annual)
Level (1.1199)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-3.0959)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.
Stock Forecast FAQ
In the current month, CTRE has received 7 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CTRE average analyst price target in the past 3 months is $33.22.
-
Where Will CareTrust REIT Stock Be In 1 Year?
According to analysts, the consensus estimate is that CareTrust REIT share price will rise to $33.22 per share over the next 12 months.
-
What Do Analysts Say About CareTrust REIT?
Analysts are divided on their view about CareTrust REIT share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CareTrust REIT is a Sell and believe this share price will drop from its current level to $32.00.
-
What Is CareTrust REIT's Price Target?
The price target for CareTrust REIT over the next 1-year time period is forecast to be $33.22 according to 8 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CTRE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CareTrust REIT is a Buy. 7 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CTRE?
You can purchase shares of CareTrust REIT via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CareTrust REIT shares.
-
What Is The CareTrust REIT Share Price Today?
CareTrust REIT was last trading at $30.31 per share. This represents the most recent stock quote for CareTrust REIT. Yesterday, CareTrust REIT closed at $30.41 per share.
-
How To Buy CareTrust REIT Stock Online?
In order to purchase CareTrust REIT stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
